Literature DB >> 15921387

Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.

Sabine Knipp, Barbara Hildebrandt, Jutta Richter, Rainer Haas, Ulrich Germing, Norbert Gattermann.   

Abstract

We report 14 cases of secondary myelodysplastic syndromes (sMDS) following treatment with azathioprine for non-malignant disorders. Long-term treatment with azathioprine seems to be associated with an increased risk of MDS and subsequent leukemic transformation.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15921387

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  19 in total

Review 1.  Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

Authors:  Kara Bradford; David Q Shih
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease.

Authors:  Manuel Aivado; Dimitrios Spentzos; Ulrich Germing; Gil Alterovitz; Xiao-Ying Meng; Franck Grall; Aristoteles A N Giagounidis; Giannoula Klement; Ulrich Steidl; Hasan H Otu; Akos Czibere; Wolf C Prall; Christof Iking-Konert; Michelle Shayne; Marco F Ramoni; Norbert Gattermann; Rainer Haas; Constantine S Mitsiades; Eric T Fung; Towia A Libermann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-12       Impact factor: 11.205

Review 3.  Therapy related CMML: a case report and review of the literature.

Authors:  Faheem Ahmed; Nadia Osman; Fred Lucas; Guy Neff; Teresa Smolarek; John M Bennett; Rami S Komrokji
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

4.  Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia.

Authors:  Koichi Takahashi; Naveen Pemmaraju; Paolo Strati; Graciela Nogueras-Gonzalez; Jing Ning; Carlos Bueso-Ramos; Rajyalakshmi Luthra; Sherry Pierce; Jorge Cortes; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Blood       Date:  2013-07-29       Impact factor: 22.113

5.  Anaemia in a renal allograft recipient: an unusual cause.

Authors:  Rapur Ram; Gudithi Swarnalatha; Chandanavalli Shyam Sunder Rao; Krishna Prasad Adiraju; Kaligotla Venkata Dakshinamurty
Journal:  Int Urol Nephrol       Date:  2013-09-22       Impact factor: 2.370

Review 6.  A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Authors:  Liping Zhang; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

7.  [Rationale for bone marrow examination in patients with inflammatory rheumatic diseases].

Authors:  Jutta G Richter; Pascal Gossen; Ulrich Germing; Sabine Blum; Barbara Hildebrandt; Stefan Braunstein; Dörte Huscher; Matthias Schneider
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

8.  Azathioprine-associated myelodysplastic syndrome in two patients with ulcerative colitis.

Authors:  Omer F Ahmad; Margaret G Keane; Sara McCartney; Asim Khwaja; Stuart L Bloom
Journal:  Frontline Gastroenterol       Date:  2013-03-20

Review 9.  [Oral cladribine for relapsing-remitting multiple sclerosis: another purine analogue or a genuine therapeutic innovation?].

Authors:  S Schmidt
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

Review 10.  Azathioprine for multiple sclerosis.

Authors:  I Casetta; G Iuliano; G Filippini
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.